Atlas Merchant Capital’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Atlas Merchant Capital’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50,000	Closed	-$542K	–	113
2023 Q3	$542K	Hold	50,000	–	–	0.11%	85
2023 Q2	$533K	Buy	+50,000	New	+$526K	0.1%	105

Atlas Merchant Capital's BIOS Position: Q4 2023 in Review

Atlas Merchant Capital sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 50,000 shares — an estimated $542K sold.

Atlas Merchant Capital first reported a position in BIOS in Q2 2023 and held it in 2 quarters. The position peaked at $542K in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Atlas Merchant Capital reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Atlas Merchant Capital sold 50,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $542K.
Atlas Merchant Capital first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q2 2023 and held it in 2 quarters.
Atlas Merchant Capital's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $542K in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Atlas Merchant Capital's 13F filing for Q4 2023, filed 13 Feb 2024.